gemcitabine has been researched along with African Lymphoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fan, JX; Guo, KY; Hung, YX; Wang, J; Xu, XJ; Ye, YB; Zhang, MW | 1 |
| Canseven, AG; Esmekaya, MA; Kayhan, H; Seyhan, N; Tuysuz, MZ | 1 |
| Jiang, R; Sairenji, T; Satoh, Y; Zhang, JL | 1 |
3 other study(ies) available for gemcitabine and African Lymphoma
| Article | Year |
|---|---|
[Honokiol combined with Gemcitabine synergistically inhibits the proliferation of human Burkitt lymphoma cells and induces their apoptosis].
Topics: Apoptosis; Biphenyl Compounds; Burkitt Lymphoma; Cell Line, Tumor; Cell Proliferation; Deoxycytidine; Drug Synergism; Gemcitabine; Humans; Lignans; Proto-Oncogene Proteins c-bcl-2 | 2014 |
Effects of microwave exposure and Gemcitabine treatment on apoptotic activity in Burkitt's lymphoma (Raji) cells.
Topics: Antimetabolites, Antineoplastic; Apoptosis; Burkitt Lymphoma; Cell Line, Tumor; Cell Survival; Combined Modality Therapy; Deoxycytidine; DNA; Flow Cytometry; Gemcitabine; Humans; Microwaves; Propidium; Radiation, Nonionizing | 2015 |
Mechanism for induction of hydroxyurea resistance and loss of latent EBV genome in hydroxyurea-treated Burkitt's lymphoma cell line Raji.
Topics: Antiviral Agents; Burkitt Lymphoma; Cell Line, Transformed; Cell Line, Tumor; Clone Cells; Deoxycytidine; Drug Resistance, Viral; Enzyme Inhibitors; Gemcitabine; Genome, Viral; Herpesvirus 4, Human; Humans; Hydroxyurea; Ribonucleotide Reductases; Virus Latency | 2004 |